Botwood Nicholas A.J.
Head of R&D, CMO
Officer
Latest Insider Transactions
9 transactions (past 365 days)
| 2026-06-12 | 2026-06-12 | SNDX Syndax Pharmaceuticals Inc | CMO | Exercise Conversion | 31,235 | $13.82 | $431,668 |
| 2026-06-12 | 2026-06-12 | SNDX Syndax Pharmaceuticals Inc | CMO | Sale | 31,235 | $18.14 | $566,603 |
| 2026-06-12 | 2026-06-12 | SNDX Syndax Pharmaceuticals Inc | CMO | Exercise Conversion | 31,235 | $13.82 | $431,668 |
| 2026-06-12 | 2026-06-11 | SNDX Syndax Pharmaceuticals Inc | CMO | Exercise Conversion | 22,515 | $13.82 | $311,157 |
| 2026-06-12 | 2026-06-11 | SNDX Syndax Pharmaceuticals Inc | CMO | Sale | 34,280 | $18.00 | $617,040 |
| 2026-06-12 | 2026-06-11 | SNDX Syndax Pharmaceuticals Inc | CMO | Exercise Conversion | 22,515 | $13.82 | $311,157 |
| 2026-02-06 | 2026-02-04 | SNDX Syndax Pharmaceuticals Inc | CMO | Award | 24,000 | $0.00 | $0 |
| 2026-02-06 | 2026-02-04 | SNDX Syndax Pharmaceuticals Inc | CMO | Award | 36,000 | $0.00 | $0 |
| 2026-02-06 | 2026-02-04 | SNDX Syndax Pharmaceuticals Inc | CMO | Award | 144,700 | $20.43 | $2,956,221 |
SNDX
CMO
Exercise Conversion
$431.7K
31,235 shares @ $13.82
Filed 2026-06-12Trade 2026-06-12
Syndax Pharmaceuticals IncSNDX
CMO
Exercise Conversion
$431.7K
31,235 shares @ $13.82
Filed 2026-06-12Trade 2026-06-12
Syndax Pharmaceuticals IncSNDX
CMO
Exercise Conversion
$311.2K
22,515 shares @ $13.82
Filed 2026-06-12Trade 2026-06-11
Syndax Pharmaceuticals IncSNDX
CMO
Exercise Conversion
$311.2K
22,515 shares @ $13.82
Filed 2026-06-12Trade 2026-06-11
Syndax Pharmaceuticals Inc